Top Markets
Coin of the day
Poolbeg Pharma PLC Poolbeg Pharma PLC

Poolbeg Pharma PLC

POLB
Classifica tra le azioni #38628
Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the... Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.
Prezzo delle azioni
$0.11565963
Capitalizzazione di mercato
$882.99K
Variazione (1 giorno)
-2.30%
Variazione (1 anno)
189.81%
Paese
GB
Scambia Poolbeg Pharma PLC (POLB)

Categoria

Cronologia dei frazionamenti azionari per Poolbeg Pharma PLC (POLB)
L’azione Poolbeg Pharma PLC (simbolo: POLB) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 14, 2026.
Una quota di POLB acquistata prima di Aug 14, 2026 equivale oggi a 0 quote di POLB.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE